AnishBadwe

200 EMA Crossover repeating itself + Great earnings expectations

看多
AnishBadwe 已更新   
NASDAQ:AVXL   Anavex Life Sciences Corp.
The 200 EMA crossover has occurred again! This time we have positive expectations of earnings as well. A good recipe for gains.
Keeping the analysis simple.

Target price: 3.5+
評論:
Stop has been placed at 2.61, below the downtrend's low.
評論:
Things not looking good as AVXL failed to hold above the 200 EMA for a second time.
交易結束:達到停損點
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。